Leading source of Financial News, Investor Forums, CEO Interviews, Financial Columnists, Stock Information

Pharma & Biotech

Add to MyProactive

Kazia Therapeutics Ltd - Kazia Therapeutics reaches milestone for Phase 1 Cantrixil trial in ovarian cancer

Kazia Therapeutics reaches milestone for Phase 1 Cantrixil trial in ovarian cancer

21 hours, 10 minutes ago

Cellmid Ltd -

Cellmid Limited outlines key components for FY2020 growth strategy

1 week, 1 day ago

Pharmaxis Ltd - Pharmaxis confident of FDA approval for cystic fibrosis inhalation medicine Bronchitol by Q1 2020

Pharmaxis hopeful of FDA approval for cystic fibrosis inhalation medicine Bronchitol by Q1 2020

1 week, 2 days ago

Kazia Therapeutics Ltd - Kazia Therapeutics concludes recruitment into Part B of its phase I ovarian cancer clinical study

Kazia Therapeutics concludes recruitment into Part B of its phase I ovarian cancer clinical study

1 week, 2 days ago

Paradigm Biopharmaceuticals Ltd - Paradigm Biopharmaceuticals files Investigational New Drug submission for ZilosulÒ with FDA

Paradigm Biopharmaceuticals files Investigational New Drug submission for ZilosulÒ with FDA

2 weeks, 1 day ago

Cellmid Ltd - Cellmid subsidiary Advangen International enters into agreement with K2B Co Ltd for distribution of évolis products

Cellmid subsidiary Advangen International enters into agreement with K2B Co Ltd for distribution of évolis products

2 weeks, 2 days ago

Greenhouse

Asterion Cannabis' Queensland project gets big boost after government ruling

2 weeks, 5 days ago

Botanix Pharmaceuticals raises $40mln to push its CBD-based skin disease treatments through the pipeline

Botanix Pharmaceuticals raises $40mln to push its CBD-based skin disease treatments through the pipeline

2 weeks, 6 days ago

doctor kaiser

FSD Pharma adds Dr Lary Kaiser and three other medical professionals to scientific advisory board

3 weeks, 2 days ago

hospital

G Medical Innovations eyes significant revenue growth in the UK and US

3 weeks, 2 days ago

Orthocell publishes positive pre-clinical trial study for CelGro nerve repair

3 weeks, 2 days ago

PromarkerD

Proteomics International Laboratories secures Indonesian patent for its diagnostic test

3 weeks, 3 days ago

LBT Innovations makes progress with US commercialisation strategy

3 weeks, 3 days ago

1564112681_Medical-marijuana-(1).jpg

Cann Group gains manufacturing licences for medicinal cannabis facilities

3 weeks, 6 days ago

Bronchitol

Pharmaxis continues to add value to portfolio assets; Bronchitol reaches pivotal stage

4 weeks ago

Imagion Biosystems receives FDA confirmation that breast cancer technology is a breakthrough device

4 weeks ago

Retail & consumer

AuMake International completes $2.8 million Broadway acquisition

4 weeks, 1 day ago

MMJ Group expands into EU by investing in leading Polish cannabis extraction company

1 month ago

brain scan

Kazia Therapeutics to begin phase I clinical trial for cancer that has spread to the brain

1 month ago

Visioneering Technologies doubles growth in key metrics during June quarter

on 19/7/19

Recommended

The rise, fall, and probable rise again of cobalt

6 days, 11 hours ago

What mineral resources and mining projects would President Trump gain for America if he did manage to purchase Greenland?

1 day, 8 hours ago

Follow us on:

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use